News Related to FDA

Related coverage linked through entity extraction aliases.

AI and New Drug Targets Advance Alzheimer's Research Pipeline

Feb 13, 2026

Artificial intelligence is increasingly used to analyze Alzheimer's datasets and inform drug discovery, while researchers identify promising new drug targets including the IDOL enzyme and somatostatin receptors that could lead to more affordable treatments.

Lyell Immunopharma Doses First Patient in Phase 3 Head-to-Head CAR T-Cell Trial for Lymphoma

Feb 12, 2026

Lyell Immunopharma has initiated dosing in its Phase III PiNACLE – H2H trial, comparing ronde-cel against approved CAR T-cell therapies for relapsed or refractory large B-cell lymphoma in second-line treatment.